40 pharma companies have shown interest in anti-COVID drug 2-DG, says DRDO

As of July 17, 40 companies have expressed interest to manufacture it and the applications are being processed, said R Sankara Narayanan, Additional Solicitor General representing DRDO

published on : 25th June 2021

Madras HC wonders why licence for DRDO’s new anti-COVID drug given to only one company

The petitioner said giving the licence to several medical companies may bring the price down. He sought the court to direct the authorities to provide the licence to multiple pharmaceutical firms.

published on : 24th June 2021

10,000 sachets of anti-COVID drug 2-DG to be available in market from today: Rajnath Singh

The anti-COVID drug has been developed by the Defence Research and Development Organisation.

published on : 27th May 2021

Even before launch, doctors prescribe DRDO's 2-DG Covid drug

The new drug 2-deoxy-D-glucose (2-DG) is said to help Covid patients with moderate and severe conditions by reducing their oxygen dependence.

published on : 21st May 2021

Registry data suggests phase-3 clinical trials for 2-DG at over 12 locations may continue till August

The third-phase trials began in January, while the phase-2 trials were conducted over a three-month period between June and September last year and involved 110 patients.

published on : 20th May 2021

Will examine data of 2-DG drug for adding it to national COVID treatment protocol: Government

At a press conference, NITI Aayog member (health) Dr V K Paul said Drugs Controller General of India (DCGI) has granted permission for emergency use of the drug after looking at the data.

published on : 18th May 2021

First batch of anti-COVID drug 2-DG to be released on Monday

The Drugs Controller General of India (DGCI) has approved the oral drug for emergency use as an adjunct therapy in moderate to severe coronavirus patients, the defence ministry said.

published on : 16th May 2021

Drug 2-DG will work wonders in fighting coronavirus, says Ex-CCMB director Rakesh Mishra

Speaking to Express, Mishra said the anti Covid-19 therapeutic application of the drug would be a major step in fighting the virus.  

published on : 9th May 2021